Association of Selective Serotonin Reuptake Inhibitors With the Risk of Type 2 Diabetes in Children and Adolescents
Although the risk is quite small, and far outweighed by their benefits, this study confirms that Serotonin Selective Reuptake Inhibitors (SSRIs) can increase the chance of developing Type 2 Diabetes.